Previous Article | Next Article 
Journal of Bacteriology, March 2001, p. 2041-2045, Vol. 183, No. 6
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.6.2041-2045.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Programmed Cell Death in Escherichia
coli: Some Antibiotics Can Trigger mazEF
Lethality
Boaz
Sat,1
Ronen
Hazan,1
Tova
Fisher,2
Hanita
Khaner,1
Gad
Glaser,2 and
Hanna
Engelberg-Kulka1,*
Departments of Molecular
Biology1 and Cellular
Biochemistry,2 The Hebrew University-Hadassah
Medical School, Jerusalem 91120, Israel
Received 1 August 2000/Accepted 3 January 2001
 |
ABSTRACT |
The discovery of toxin-antitoxin gene pairs (also called addiction
modules) on extrachromosomal elements of Escherichia coli, and particularly the discovery of homologous modules on the bacterial chromosome, suggest that a potential for programmed cell death may be
inherent in bacterial cultures. We have reported on the E. coli
mazEF system, a regulatable addiction module located on the
bacterial chromosome. MazF is a stable toxin and MazE is a labile
antitoxin. Here we show that cell death mediated by the E. coli
mazEF module can be triggered by several antibiotics (rifampicin, chloramphenicol, and spectinomycin) that are general inhibitors of
transcription and/or translation. These antibiotics inhibit the
continuous expression of the labile antitoxin MazE, and as a result,
the stable toxin MazF causes cell death. Our results have implications
for the possible mode(s) of action of this group of antibiotics.
 |
INTRODUCTION |
In Escherichia coli
cultures, programmed cell death is mediated through a unique genetic
system. This system, called an "addiction module," consists of a
pair of genes that specify for two components: a stable toxin and an
unstable antitoxin which prevents the lethal action of the toxin. Until
recently, such genetic systems for bacterial programmed cell death have
been found mainly in E. coli on low-copy-number plasmids,
where they are responsible for what is called the postsegregational
killing effect. When bacteria lose the plasmid(s) (or other
extrachromosomal elements), the cured cells are selectively killed
because the unstable antitoxin is degraded faster than is the more
stable toxin (6, 9, 14, 27). Thus, the cells are
"addicted" to the short-lived product, since its de novo synthesis
is essential for cell survival (27). Therefore, these
addiction modules have been implicated as having a role in maintaining
stability in the host of the extrachromosomal elements on which they
are borne (6, 9, 14, 27).
Pairs of genes homologous to some of these extrachromosomal addiction
modules have been found on the E. coli chromosome (1, 11, 12, 15-17). Members of our group have reported on the
E. coli mazEF system, the first known regulatable
prokaryotic chromosomal addiction module (1). The
mazEF module consists of two adjacent genes, mazE
and mazF, located in the rel operon downstream
from the relA gene (17). In the study by
members of our group (1), mazEF was found to
have the properties required for an addiction module: (i) MazF is toxic
and MazE is antitoxic; (ii) MazF is long lived, while MazE is a labile
protein degraded in vivo by the ATP-dependent ClpPA serine protease;
(iii) MazE and MazF interact; and (iv) MazE and MazF are coexpressed.
Moreover, the mazEF system has a unique property: its
expression is inhibited by guanosine 3',5'-bispyrophosphate (ppGpp),
which is synthesized under conditions of extreme amino acid starvation
by the RelA protein (4). Based on these properties of
mazEF and on the requirement for the continuous expression
of MazE to prevent cell death, members of our group offered a model for
programmed cell death under conditions of nutrient starvation
(1). This model was further supported by the results of
our previous experiments showing that mazEF-mediated cell
death is induced by the artificial overproduction of ppGpp (1,
8), leading to high concentrations that might not be found under
normal physiological conditions, even when the cells suffer from
extreme nutrient starvation.
Here we ask: in E. coli, can mazEF-mediated cell
death be triggered under the specific physiological condition of the
inhibition of RNA and/or protein synthesis? To create this condition we
briefly treated the bacterial cells with a low concentration of one of several antibiotics known to inhibit transcription and/or translation in E. coli. We found that such antibiotics can indeed
trigger mazEF-mediated cell death by reducing the level of MazE.
 |
MATERIALS AND METHODS |
Materials and media.
[35S]methionine (>800
Ci/mmol [1 Ci = 37 GBq]) was obtained from Amersham (Little
Chalfont, England). The antibiotics rifampin, chloramphenicol,
spectinomycin, and ampicillin were obtained from Sigma (St. Louis,
Mo.). Polycolonal antibodies against E. coli MazE and TrpR
were prepared by injecting purified His-tagged MazE and TrpR proteins
into rabbits (13). Bacteria were grown in M9 medium
(14) with a mixture of amino acids (20 µg/ml each) or in
Luria-Bertani medium (LB) (18).
Bacterial strains.
The E. coli strains used in
this study were MC4100 relA+ [genotype,
araD139
(argF-lac)205 flb-5301 pstF25
rpsL150 deoC1 (wild type) (8)] and its derivatives
MC4100 relA+
mazEF::kan (
mazEF)
(8) and MC4100 relA+
clpP::cat (
clpP). The latter
was constructed here by P1 transduction from the strain MC4100
clpP::cat (1).
Activation by antibiotics of mazEF-mediated
killing.
Cells were grown in M9 (with a mixture of 20 µg of each
amino acid/ml) or LB medium (18) with shaking (160 rpm) at
37°C. At mid-logarithmic phase (optical density at 600 nm
[OD600], 0.4 to 0.6), to each sample we added one of the
antibiotics at the following final concentrations: 5 to 25 µg of
rifampin/ml in M9 and 15 to 25 µg of rifampin/ml in LB, 15 µg of
chloramphenicol/ml, 200 µg of spectinomycin/ml or 100 µg of
ampicillin/ml both in M9 and in LB. The results of the experiments
shown in Fig. 1A to D were observed under conditions in which we used
the minimal concentrations of antibiotics at which they were effective.
The cells were incubated at 37°C for 10 min, washed in LB, diluted, plated on LB plates, and incubated at 37°C for 18 h. Note that both the LB liquid medium used for washing and diluting and the LB
plates were prewarmed to 37°C. Cell survival was calculated by
comparing the colony-forming ability of cells treated by antibiotics to
that of untreated cells.
Assay for the effect of antibiotics on protein synthesis.
We
measured the incorporation of [35S]methionine into a
trichloroacetic acid (TCA)-insoluble fraction. Cultures were grown in M9 medium without methionine at 37°C to mid-logarithmic phase (OD600, 0.4 to 0.6). To each 1-ml sample of culture a
solution of a single antibiotic (25 µg of rifampin/ml, 15 µg of
chloramphenicol/ml, and 100 µg of spectinomycin/ml) was added. The
culture was labeled with 0.2 µCi/ml in [35S]methionine
in a final concentration of 2 µg of unlabeled methionine/ml. At
various time intervals, the reactions were stopped by the addition of
TCA to a final concentration of 10%, after which the reaction tubes
were put in ice. The samples were centrifuged at 14,000 rpm for 5 min in Eppendorf centrifuge 5417C. The pellets were washed twice with
5% TCA and then twice with acetone. The TCA-insoluble counts were
determined by using a scintillation counter (BETAmatic I/II; KONTRON).
Determination of the cellular levels of E. coli MazE
and TrpR.
The cultures were grown in LB or M9 media with shaking
at 37°C. When the cultures reached an OD600 of 0.25 (time
zero), one of the following antibiotics at the specified concentration
was added to each culture: 200 µg of rifampin/ml, 50 µg of
chloramphenicol/ml, or 200 µg of spectinomycin/ml. Over a period of
90 min, equal volumes (100 µl) of samples that were grown in M9 or LB
were withdrawn and then immediately centrifuged at 3,000 rpm at room
temperature for 10 min in Eppendorf centrifuge 5417C. The collected
cells were resuspended in 0.5 ml of TE buffer (20 mM Tris, 1 mM EDTA [pH 8.0]), lysed by sonication for 30 s, and centrifuged at
14,000 rpm at 4°C for 30 min in Eppendorf centrifuge 5417C. The
supernatants were loaded on 16.5% Tricine-SDS polyacrylamide gels.
Electrophoresis was carried out at 150 V overnight. Proteins were
transferred onto a nitrocellulose membrane at 100 V for 1.5 h.
Western analysis was carried out using MazE or TrpR polyclonal
antibodies as primary antibodies which were prepared in rabbits by
injecting His-tagged purified MazE and TrpR proteins (13).
The secondary antibody was horseradish peroxidase goat anti-rabbit
immunoglobulin G. MazE and TrpR were detected through the enhanced
chemiluminescence reaction after an exposure to a sensitive film.
 |
RESULTS |
Antibiotics that inhibit transcription and/or translation in
E. coli trigger mazEF-mediated death.
As a
transcriptional inhibitor we chose the antibiotic rifampin, known to
inhibit the initiation of RNA synthesis through its interaction with
the
-subunit of RNA polymerase (7, 25). As
translational inhibitors we chose the antibiotics chloramphenicol and
spectinomycin, which are known to affect the machinery of translation
elongation: chloramphenicol acts on the 50S ribosomal subunit to
inhibit the petidyl transferase reaction, and spectinomycin affects
tRNA translocation (7, 24). We compared the viability of
wild-type E. coli MC4100 relA+ to the
viability of its
mazEF and
clpP derivatives
after exposing each of these strains to antibiotics in M9 medium at
37°C over 60 min. Even after only a short exposure (10 min) to
rifampin (Fig. 1A and C),
chloramphenicol (Fig. 1B and C), or
spectinomycin (data not shown and Fig. 1C), it was clear that cell
death was both mazEF mediated and clpP dependent.
In each case the antibiotics caused most (85 to 95%) of the wild-type
E. coli cells to die. In contrast, under identical
conditions, we observed almost no killing of the
mazEF
and
clpP derivatives. In addition, we observed similar
results when we tested the effect of these antibiotics on the cell
viability of E. coli B (BL21) and its
mazEF
derivatives (data not shown). Four important points should be noted.
(i) Cells rendered nonviable by the antibiotics do not form colonies
(even after several weeks); however, no lysis was observed in the test tubes and by a microscope (data not shown). (ii) About 10% of the
subpopulation of cells survive antibiotic treatment, and that cannot be
attributed to antibiotic resistance and/or to resistance to
mazEF-mediated cell death. When we re-treated the surviving subpopulation with the same antibiotic we found the same results: 90%
of the culture suffered mazEF-mediated death, and 10%
survived (data not shown). (iii) Although in the presence of the
antibiotics under study,
mazEF mutants remain viable
(Fig. 1A to C), they still remain sensitive to these drugs: protein
synthesis (Fig. 1E to F) and cell growth rates (data not shown) are
inhibited equally in the wild-type and their
mazEF
derivative strains. (iv) Obviously, rifampin did not trigger
mazEF-dependent killing in rifampin-resistant mutants, nor
did chloramphenicol or spectinomycin in chloramphenicol-resistant or
spectinomycin-resistant mutants respectively (data not shown).
Therefore, as we shall explain below, we suggest that the
mazEF-mediated death may be a consequence of the inhibition
of transcription and/or translation that can be triggered by these
antibiotics. This idea is supported by the fact that wild-type and
mazEF cells were affected similarly by the cell wall
synthesis inhibitor ampicillin (7) (Fig. 1C and D).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Antibiotics that inhibit transcription and/or
translation in E. coli induce mazEF-dependent
cell death. Viability plotted against the time of exposure to rifampin
(A) and chloramphenicol (B) in M9 medium of E. coli MC4100
relA+ (WT) (x) and its mazEF
( EF) (O) and clpP ( ) derivatives is
shown. (C) The viability of E. coli MC4100
relA+ (WT) and its mazEF
( EF) and clpP derivatives in M9 medium
either untreated (C, control) or treated for 10 min with rifampin
(Rif), chloramphenicol (Cam), spectinomycin (Spc), or ampicillin (Amp).
(D) As for panel C but in LB medium. (E) The effects in M9 medium of
the antibiotics (untreated cells, ; rifampin, ; chloram phenicol, ; spectinomycin, ) on protein synthesis in
E. coli MC4100 relA+. (F) As for
panel E but in the derivative strain MC4100
relA+ mazEF. The effects of the
antibiotics on mazEF-mediated killing and on protein
synthesis were measured as described in Materials and Methods.
|
|
The effect on the cellular level of MazE of antibiotics that
inhibit transcription and/or translation.
We hypothesized that the
antibiotics rifampin, chloramphenicol, and spectinomycin triggered
mazEF-mediated killing by inhibiting the continuous
expression of the labile antitoxin MazE. As a result, the remaining,
stable toxin, MazF, caused cell death. To test this hypothesis, we
studied the effect of these antibiotics on the cellular levels of MazE
(Fig. 2A). So far, no chromosome-borne component of an addiction module has been detected. Here, we determined the cellular level of MazE by Western analysis using antibodies that we
prepared against purified MazE (see Materials and Methods). In our
control cultures of untreated cells in M9 medium, we found a constant
level of MazE over a period of 90 min. In contrast, upon the addition
of rifampin, the level of MazE was already drastically reduced after
only 10 min. When we added chloramphenicol or spectinomycin to cells
growing in M9 medium, the reduction in the level of MazE started after
10 min, and by 90 min MazE was barely detectable (Fig. 2A). Under our
experimental conditions, it was not possible to determine the MazE/MazF
ratios, because though we could detect the cellular levels of the
chromosomally directed antitoxic protein MazE (with anti-MazE
antibodies), we were unable to do so for the toxic protein MazF (with
anti-MazF antibodies). Using anti-MazF antibodies, we could detect MazF
only when it was either purified or expressed by plasmid-borne
mazF. Since in the case of each of the known
extrachromosomal addiction modules the antitoxic protein is produced in
excess over the toxic protein (for a review, see reference
9), it seems that the level of the toxic MazF protein
expressed from the chromosome-borne gene was too low to be detected.
Therefore, instead we studied the effect of rifampin, chloramphenicol,
and spectinomycin on the cellular levels of another E. coli
protein, TrpR (the Trp repressor) (19). We choose TrpR because like MazF (9 kDa), TrpR (12 kDa) is a small E. coli
protein found in low intracellular concentrations. Unlike the
short-lived MazE, however, TrpR is known to be stable (19)
and therefore it resembles the stable MazF (1). As we
expected, in cells treated with each of the antibiotics, in contrast to
the reduced levels of the labile protein MazE (Fig. 2A), the levels of
TrpR remained constant (Fig. 2C). Note that in M9 medium, the cellular level of MazE is significantly lower than it is in LB medium (compare Fig. 2A and B). In LB medium, compared to the control samples, 10 min
after the addition of rifampin we detected a significant reduction in
the level of MazE, which remained at very low levels during the whole
course of the experiment (10 to 90 min) (Fig. 2B). Similarly, 10 min
after we added chloramphenicol or spectinomycin, we also found reduced
levels of MazE. However, these reduced levels were still significantly
higher than those in cells treated with rifampin, and they remained
constant over the whole period of the experiment (Fig. 2B).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Antibiotics that inhibit transcription and/or
translation in E. coli affect the level of MazE. (A) The
level of E. coli MazE in M9 medium. (B) The level of
E. coli MazE in LB medium. (C) The level of E. coli TrpR protein in M9 medium. The experiments were carried out
with E. coli strain MC4100 relA+ for
90 min in the presence of rifampicin, chloramphenicol, or spectinomycin
or without any antibiotics (control) as described in Materials and
Methods.
|
|
The effect on mazEF-mediated cell death in LB medium of
antibiotics that inhibit transcription and/or translation.
As in
M9 medium, we also tested the effects of adding the antibiotic
rifampin, spectinomycin, or chloramphenicol to cultures in LB medium
(Fig. 1D). In LB, the difference in the effect on MazE levels between
cells treated by rifampin and cells treated by chloramphenicol or
spectinomycin (Fig. 2B) is reflected in the differing effect(s) of
these drugs on cell viability (Fig. 1D). mazEF-mediated
killing triggered by rifampin left only 5% survivors in M9 medium
(Fig. 1C) and 20% survivors in LB medium (Fig. 1D). On the other hand,
in LB medium chloramphenicol did not trigger mazEF-dependent
death (Fig. 1D). This was true in LB even when we increased the
concentration of chloramphenicol more than 10 times, to 200 µg/ml
(data not shown). In the case of spectinomycin in LB, we observed only
30% mazEF-mediated killing (Fig. 1D). It appears that in LB
medium, even after the addition of either chloramphenicol or
spectinomycin, the levels of MazE remained high enough to prevent cell
death by MazF (Fig. 2D).
 |
DISCUSSION |
The main finding of this work is that E. coli
mazEF-mediated cell death can be triggered by several antibiotics,
such as rifampin, chloramphenicol, or spectinomycin (Fig. 1A to C) that
are general inhibitors of transcription and/or translation (7,
24, 25). We have also shown that these antibiotics reduce the
cellular level of the antitoxic labile protein MazE (Fig. 2A) and seem thereby to permit the lethal action of the toxic protein MazF. The
effect of the antibiotics both on cell death and on the reduction in
the cellular level of MazE is particularly apparent in M9 medium (Fig.
1C and 2A). In our experiments, we determined two parameters. One is
cell death which was determined by cell viability after 18 h (Fig.
1A to C) and which is the result of multiple processes. The other is
the level of the MazE protein, which we determined at several time
points during the first 90 min of our experiments (Fig. 2A) and which
represents only one step in the process of cell death. We observed a
correlation between the initial reduction in the levels of MazE and the
overall loss in cell viability. This correlation is valid not only in
the case of treatment by rifampin, where MazE was not detectable after
10 min, but even in the cases of treatment by chloramphenicol and
spectinomycin, where the reduction in MazE was seen only after 60 to 90 min (Fig. 2A). In addition, our results clearly show that even in M9
medium the transcription inhibitor rifampin triggered MazE degradation and cell death more effectively than did chloramphenicol or
spectinomycin. As we mentioned earlier, ppGpp, the signal molecule for
nutrient starvation (4), leads to the inhibition of
mazEF transcription (1). Both ppGpp and
rifampin bind to the
-subunit of RNA polymerase (5,
22). Therefore, rifampin may have been more effective than
chloramphenicol or spectinomycin. In addition, we observed that
E. coli strain MC4100 (carrying the mutation
relA1) (3) is less sensitive to the
mazEF-mediated cell death triggered by the herein-described
antibiotics than is the same E. coli strain carrying the
wild-type relA+ gene (data not shown). E. coli MC4100 relA1 produces lower levels of ppGpp than
the wild-type relA+ strain (4). It
seems, therefore, that ppGpp may be involved in the
mazEF-mediated killing even when it is triggered by
antibiotics that inhibit transcription and/or translation. This
assumption is under our current investigation.
In LB medium, only when we used rifampin did we detect both significant
mazEF-dependent killing (Fig. 1D) and a reduction in the
cellular level of MazE (Fig. 2B). Nevertheless, both of these effects
of rifampin were less drastic in LB than they were in M9 medium (Fig.
1C and D and 2A and B). Furthermore, in LB medium, neither
chloramphenicol nor spectinomycin had a significant effect on cell
viability (Fig. 1D). In addition, the levels of MazE were significantly
higher than those in cells treated with rifampin (Fig. 2B) and probably
high enough to prevent the killing of MazF. The differences among the
actions of the various antibiotics observed in M9 and LB media can be
explained by the cellular levels of MazE, which were significantly
lower in M9 medium than they were in LB (compare Fig. 2A and B). In
addition to other possible explanations, we suggest that in cells
growing in the rich LB medium, the high level of low-molecular-weight
peptides offers more substrates to compete for degradation by ClpPA,
thus somewhat protecting MazE itself from degradation. This possibility
is further supported by our results showing similar levels of TrpR in
cells grown in either LB or M9 medium (data not shown). Since TrpR is a
stable protein (Fig. 2C) and thus not a substrate for ClpPA, it should
not be affected by the low-molecular-weight peptides in LB medium.
The results that we report here broaden our previous model of
programmed cell death mediated by the mazEF system
(1). Previously, members of our group based the model only
on the artificial overexpression of MazF or ppGpp (1, 8).
Here we base our model on conditions that are more similar to
physiological conditions in which inhibition of transcription or
translation occurs, i.e., conditions of stress. We found that even
briefly inhibiting transcription and/or translation by antibiotics was
sufficient to induce mazEF-mediated cell death. As
illustrated in Fig. 3, the inhibition of
protein synthesis will prevent the de novo synthesis of the labile
antideath protein MazE, thus triggering mazEF-mediated
death. The MazE protein already present in the cell continues to be
degraded by the ClpPA protease. As a result, the level of MazE is
reduced below the threshold required for antagonizing the toxic protein
MazF, leading to cell death. Thus, we suggest that the choice between
cell survival and cell death depends on the level of MazE. Inhibiting
transcription and/or translation selectively reduced the cellular level
of the antitoxic labile protein MazE (Fig. 2A and B) and thus probably permitted the lethal action of the toxic protein MazF (Fig. 3). Our
model is further supported by the recent results of members of our
group on postsegregational killing mediated by the addiction module
phd-doc of plasmid prophage P1 (13a). This
module consists of two genes; doc codes for a stable toxin,
and phd codes for a labile antitoxin (reviewed in references
9 and 27). In our new study we show the following: (i) the
postsegregational killing effect of P1 phd-doc requires the
presence of the E. coli mazEF system, and (ii) under
conditions of P1 phd-doc postsegregational killing the
protein synthesis in E. coli is inhibited. This inhibition is probably caused by the Doc protein, which was recently described as
being a translational inhibitor (9; Yarmolinsky, personal communication). Thus, inhibition of protein synthesis either by antibiotics or by the Doc protein triggers the E. coli
mazEF-mediated death.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
A schematic representation of the induction of the
E. coli mazEF-mediated cell death by antibiotics that
inhibit transcription and/or translation (see the text).
|
|
In analogy to the programmed cell death apparatus in eukaryotic cells
(20, 26), it seems that the suicide machinery in bacterial
cells is always present: it only requires a trigger to activate it.
Moreover, at least for E. coli, the straightforward choice
is death caused by a stable intracellular toxin (in this case MazF).
The choice of life over the "default" death requires a dynamic
antagonistic process manifested either by the continued production of
the unstable antitoxin (in this case MazE) or by a process that would
prevent the degradation of the unstable antitoxin (9).
Thus, cell death could be caused by anything that would prevent the
continuous expression of the antitoxic protein MazE. Our results,
showing that the mazEF system is responsible for approximately 90% killing by rifampin, may illuminate the until now
elusive cause of E. coli killing by rifampin
(23). Furthermore, though chloramphenicol and
spectinomycin are traditionally considered to be bacteriostatic
(2, 23), we found that these antibiotics were actually
bacteriocidal in M9 medium. It seems likely that until now these
antibiotics have not been revealed to be bacteriocidal because they had
been tested in rich media like LB (2, 10, 21), where we
found that the level of the antitoxic protein MazE remained high (Fig.
2B). Thus, we suggest that the traditional distinction between
"bacteriostatic" and "bacteriocidal" should not be taken
as absolute and should be reconsidered. Moreover, now we can add
"triggering bacterial cell suicide" to the other well-documented
modes of action of such antibiotics.
 |
ACKNOWLEDGMENTS |
We thank Sudersan Narasimhan for his help. We are deeply grateful
to F. R. Warshaw-Dadon (Jerusalem, Israel) for her critical reading of the manuscript.
This research was supported by a grant of the Israel Science Foundation
administrated by the Israel Academy of Science and Humanities.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology, The Hebrew University-Hadassah Medical School,
P.O. Box 12272, Jerusalem 91120, Israel. Phone: 972-2-675-8250. Fax: 972-2-678-4010. E-mail: hanita{at}cc.huji.ac.il.
 |
REFERENCES |
| 1.
|
Aizenman, E.,
H. Engelberg-Kulka, and G. Glaser.
1996.
An Escherichia coli chromosomal "addiction module" regulated by ppGpp: a model for programmed cell death.
Proc. Natl. Acad. Sci. USA
93:6059-6063[Abstract/Free Full Text].
|
| 2.
|
Brock, T. D.
1961.
Chloramphenicol.
Bacteriol. Rev.
25:32-48.
|
| 3.
|
Casadaban, M. J., and S. N. Cohen.
1979.
Lactose genes fused to exogenous promoters in one step using a Mu-lac bacteriophage: in vivo probe for transcriptional control sequences.
Proc. Natl. Acad. Sci. USA
76:4530-4533[Abstract/Free Full Text].
|
| 4.
|
Cashel, M.,
D. R. Gentry,
V. Z. Hernandez, and D. Vinella.
1996.
The stringent response, p. 1458-1496.
In
F. C. Neidhardt, R. Curtis III, J. L. Ingraham, E. C. C. Lin, K. B. M. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C.
|
| 5.
|
Chatterji, D.,
N. Fujita, and A. Ishihama.
1998.
The mediator for stringent control, ppGpp, binds to the beta-subunit of Escherichia coli RNA polymerase.
Genes Cells
3:279-287[Abstract].
|
| 6.
|
Couturier, M.,
E. M. Bahassi, and L. Van Melderen.
1998.
Bacterial death by DNA gyrase poisoning.
Trends Microbiol.
6:269-275[CrossRef][Medline].
|
| 7.
|
Davies, J., and V. Webb.
1998.
Antibiotic resistance in bacteria, p. 239-273.
In
R. M. Krause (ed.), Emerging infections. Academic Press, New York, N.Y.
|
| 8.
|
Engelberg-Kulka, H.,
M. Reches,
S. Narasimhan,
R. Schoulaker-Schwarz,
Y. Klemes,
E. Aizenman, and G. Glaser.
1998.
rexB of bacteriophage is an anti-cell death gene.
Proc. Natl. Acad. Sci. USA
95:15481-15486[Abstract/Free Full Text].
|
| 9.
|
Engelberg-Kulka, H., and G. Glaser.
1999.
Addiction modules and programmed cell death and antideath in bacterial cultures.
Annu. Rev. Microbiol.
53:43-70[CrossRef][Medline].
|
| 10.
|
Fassin, W.,
R. Hengel, and P. Klein.
1955.
Bakteriostase und Bakterizidie als Alternativen des antibakteriellen Chloramphenicoleffektes.
Z. Hyg.
141:S363-S375[CrossRef].
|
| 11.
|
Gerdes, K.,
A. P. Gultyaev,
T. Franch,
K. Pederson, and N. D. Milkkelsen.
1997.
Antisense RNA-regulated programmed cell death.
Annu. Rev. Genet.
19:49-61.
|
| 12.
|
Gotfredsen, M., and K. Gerdes.
1998.
The Escherichia coli relBE genes belong to a new toxin-antitoxin gene family.
Mol. Microbiol.
29:1065-1076[CrossRef][Medline].
|
| 13.
|
Harlow, E., and D. Lane.
1998.
Immunization, p. 53-137.
In
antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 13a.
|
Hazan, R.,
B. Sat,
M. Reches, and H. Engelberg-Kulka.
2001.
Postsegregational killing mediated by the P1 phage "addiction module" phd-doc requires the Escherichia coli programmed cell death system mazEF.
J. Bacteriol.
183:2046-2050[Abstract/Free Full Text].
|
| 14.
|
Jensen, R. B., and K. Gerdes.
1995.
Programmed cell death in bacteria: proteic plasmid stabilization systems.
Mol. Microbiol.
17:205-210[CrossRef][Medline].
|
| 15.
|
Masuda, Y.,
K. Miyakawa,
Y. Nishimura, and E. Ohtsubo.
1993.
chpA and chpB, Escherichia coli chromosomal homologs of the pem locus responsible for stable maintenance of plasmid R100.
J. Bacteriol.
175:6850-6856[Abstract/Free Full Text].
|
| 16.
|
Masuda, Y., and E. Ohtsubo.
1994.
Mapping and disruption of the chpB locus in Escherichia coli.
J. Bacteriol.
176:5861-5863[Abstract/Free Full Text].
|
| 17.
|
Metzger, S.,
I. B. Dror,
E. Aizenman,
G. Schreiber,
M. Toone,
J. D. Friesen,
M. Cashel, and G. Glaser.
1988.
The nucleotide sequence and characterization of the relA gene of Escherichia coli.
J. Biol. Chem.
263:15699-15704[Abstract/Free Full Text].
|
| 18.
|
Miller, J. H.
1972.
Experiments in molecular genetics, p. 205-210.
Cold Spring Harbor Laboratory Press, Plainview, N.Y.
|
| 19.
|
Pittard, A. J.
1996.
Biosynthesis of the aromatic amino acids, p. 458-484.
In
F. C. Neidhardt, R. Curtis III, J. L. Ingraham, E. C. C. Lin, K. B. M. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. American Society for Microbiology, Washington, D.C.
|
| 20.
|
Raff, M.
1998.
Cell suicide for beginners.
Nature
306:119-122[CrossRef].
|
| 21.
|
Rahal, J. J., Jr., and M. S. Simberkoff.
1979.
Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens.
Antimicrob. Agents Chemother.
16:13-18[Abstract/Free Full Text].
|
| 22.
|
Reddy, P. S.,
A. Raghavan, and D. Chatterji.
1995.
Evidence for a ppGpp-binding site on Escherichia coli RNA polymerase: proximity relationship with the rifampicin-binding domain.
Mol. Microbiol.
15:255-265[CrossRef][Medline].
|
| 23.
|
Schlessinger, D., and B. Eisenstein.
1998.
Biological basis for antibacterial action, p. 52-61.
In
M. Schaechter, N. C. Engleberg, B. Eisenstein, and G. Medoff (ed.), Microbial Disease, 3rd ed. Williams & Wilkins, New York, N.Y.
|
| 24.
|
Spahn, C. M. T., and C. D. Prescott.
1996.
Throwing a spanner in the works: antibiotics and the translation apparatus.
J. Mol. Biol.
74:423-439.
|
| 25.
|
Wehrli, W., and M. Staehelin.
1971.
Actions of the rifampicins.
Bacteriol. Rev.
35:290-309[Free Full Text].
|
| 26.
|
Weil, M.,
M. D. Jacobson,
H. S. Coles,
T. J. Davies,
R. L. Gardner,
K. D. Raff, and M. C. Raff.
1996.
Constitutive expression of the machinery for programmed cell death.
J. Cell Biol.
133:1053-1059[Abstract/Free Full Text].
|
| 27.
|
Yarmolinsky, M. B.
1995.
Programmed cell death in bacterial population.
Science
267:836-837[Free Full Text].
|
Journal of Bacteriology, March 2001, p. 2041-2045, Vol. 183, No. 6
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.6.2041-2045.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kolodkin-Gal, I., Engelberg-Kulka, H.
(2009). The Stationary-Phase Sigma Factor {sigma}S Is Responsible for the Resistance of Escherichia coli Stationary-Phase Cells to mazEF-Mediated Cell Death. J. Bacteriol.
191: 3177-3182
[Abstract]
[Full Text]
-
Donegan, N. P., Cheung, A. L.
(2009). Regulation of the mazEF Toxin-Antitoxin Module in Staphylococcus aureus and Its Impact on sigB Expression. J. Bacteriol.
191: 2795-2805
[Abstract]
[Full Text]
-
Fu, Z., Tamber, S., Memmi, G., Donegan, N. P., Cheung, A. L.
(2009). Overexpression of MazFSa in Staphylococcus aureus Induces Bacteriostasis by Selectively Targeting mRNAs for Cleavage. J. Bacteriol.
191: 2051-2059
[Abstract]
[Full Text]
-
Korch, S. B., Contreras, H., Clark-Curtiss, J. E.
(2009). Three Mycobacterium tuberculosis Rel Toxin-Antitoxin Modules Inhibit Mycobacterial Growth and Are Expressed in Infected Human Macrophages. J. Bacteriol.
191: 1618-1630
[Abstract]
[Full Text]
-
Saavedra De Bast, M., Mine, N., Van Melderen, L.
(2008). Chromosomal Toxin-Antitoxin Systems May Act as Antiaddiction Modules. J. Bacteriol.
190: 4603-4609
[Abstract]
[Full Text]
-
Kolodkin-Gal, I., Engelberg-Kulka, H.
(2008). The Extracellular Death Factor: Physiological and Genetic Factors Influencing Its Production and Response in Escherichia coli. J. Bacteriol.
190: 3169-3175
[Abstract]
[Full Text]
-
Rice, K. C., Bayles, K. W.
(2008). Molecular Control of Bacterial Death and Lysis. Microbiol. Mol. Biol. Rev.
72: 85-109
[Abstract]
[Full Text]
-
Drlica, K., Malik, M., Kerns, R. J., Zhao, X.
(2008). Quinolone-Mediated Bacterial Death. Antimicrob. Agents Chemother.
52: 385-392
[Full Text]
-
Fu, Z., Donegan, N. P., Memmi, G., Cheung, A. L.
(2007). Characterization of MazFSa, an Endoribonuclease from Staphylococcus aureus. J. Bacteriol.
189: 8871-8879
[Abstract]
[Full Text]
-
Villalba, J. D., Gomez, C., Medel, O., Sanchez, V., Carrero, J. C., Shibayama, M., Ishiwara, D. G. P.
(2007). Programmed cell death in Entamoeba histolytica induced by the aminoglycoside G418. Microbiology
153: 3852-3863
[Abstract]
[Full Text]
-
Villain-Guillot, P., Gualtieri, M., Bastide, L., Leonetti, J.-P.
(2007). In Vitro Activities of Different Inhibitors of Bacterial Transcription against Staphylococcus epidermidis Biofilm. Antimicrob. Agents Chemother.
51: 3117-3121
[Abstract]
[Full Text]
-
Tsilibaris, V., Maenhaut-Michel, G., Mine, N., Van Melderen, L.
(2007). What Is the Benefit to Escherichia coli of Having Multiple Toxin-Antitoxin Systems in Its Genome?. J. Bacteriol.
189: 6101-6108
[Abstract]
[Full Text]
-
Magnuson, R. D.
(2007). Hypothetical Functions of Toxin-Antitoxin Systems. J. Bacteriol.
189: 6089-6092
[Full Text]
-
Montero, C. I., Johnson, M. R., Chou, C.-J., Conners, S. B., Geouge, S. G., Tachdjian, S., Nichols, J. D., Kelly, R. M.
(2007). Responses of Wild-Type and Resistant Strains of the Hyperthermophilic Bacterium Thermotoga maritima to Chloramphenicol Challenge. Appl. Environ. Microbiol.
73: 5058-5065
[Abstract]
[Full Text]
-
Wilbaux, M., Mine, N., Guerout, A.-M., Mazel, D., Van Melderen, L.
(2007). Functional Interactions between Coexisting Toxin-Antitoxin Systems of the ccd Family in Escherichia coli O157:H7. J. Bacteriol.
189: 2712-2719
[Abstract]
[Full Text]
-
Nieto, C., Cherny, I., Khoo, S. K., de Lacoba, M. G., Chan, W. T., Yeo, C. C., Gazit, E., Espinosa, M.
(2007). The yefM-yoeB Toxin-Antitoxin Systems of Escherichia coli and Streptococcus pneumoniae: Functional and Structural Correlation. J. Bacteriol.
189: 1266-1278
[Abstract]
[Full Text]
-
Budde, P. P., Davis, B. M., Yuan, J., Waldor, M. K.
(2007). Characterization of a higBA Toxin-Antitoxin Locus in Vibrio cholerae. J. Bacteriol.
189: 491-500
[Abstract]
[Full Text]
-
Moritz, E. M., Hergenrother, P. J.
(2007). Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. Proc. Natl. Acad. Sci. USA
104: 311-316
[Abstract]
[Full Text]
-
Morganroth, P. A., Hanawalt, P. C.
(2006). Role of DNA Replication and Repair in Thymineless Death in Escherichia coli.. J. Bacteriol.
188: 5286-5288
[Abstract]
[Full Text]
-
Korch, S. B., Hill, T. M.
(2006). Ectopic Overexpression of Wild-Type and Mutant hipA Genes in Escherichia coli: Effects on Macromolecular Synthesis and Persister Formation. J. Bacteriol.
188: 3826-3836
[Abstract]
[Full Text]
-
Kolodkin-Gal, I., Engelberg-Kulka, H.
(2006). Induction of Escherichia coli Chromosomal mazEF by Stressful Conditions Causes an Irreversible Loss of Viability. J. Bacteriol.
188: 3420-3423
[Abstract]
[Full Text]
-
Harder, S., Bente, M., Isermann, K., Bruchhaus, I.
(2006). Expression of a Mitochondrial Peroxiredoxin Prevents Programmed Cell Death in Leishmania donovani. Eukaryot Cell
5: 861-870
[Abstract]
[Full Text]
-
Engelberg-Kulka, H., Hazan, R., Amitai, S.
(2005). mazEF: a chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria. J. Cell Sci.
118: 4327-4332
[Abstract]
[Full Text]
-
Lah, J., Simic, M., Vesnaver, G., Marianovsky, I., Glaser, G., Engelberg-Kulka, H., Loris, R.
(2005). Energetics of Structural Transitions of the Addiction Antitoxin MazE: IS A PROGRAMMED BACTERIAL CELL DEATH DEPENDENT ON THE INTRINSICALLY FLEXIBLE NATURE OF THE ANTITOXINS?. J. Biol. Chem.
280: 17397-17407
[Abstract]
[Full Text]
-
McKinley, J. E., Magnuson, R. D.
(2005). Characterization of the Phd Repressor-Antitoxin Boundary. J. Bacteriol.
187: 765-770
[Abstract]
[Full Text]
-
Keren, I., Shah, D., Spoering, A., Kaldalu, N., Lewis, K.
(2004). Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli. J. Bacteriol.
186: 8172-8180
[Abstract]
[Full Text]
-
Amitai, S., Yassin, Y., Engelberg-Kulka, H.
(2004). MazF-Mediated Cell Death in Escherichia coli: a Point of No Return. J. Bacteriol.
186: 8295-8300
[Abstract]
[Full Text]
-
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., Leibler, S.
(2004). Bacterial Persistence as a Phenotypic Switch. Science
305: 1622-1625
[Abstract]
[Full Text]
-
Hazan, R., Sat, B., Engelberg-Kulka, H.
(2004). Escherichia coli mazEF-Mediated Cell Death Is Triggered by Various Stressful Conditions. J. Bacteriol.
186: 3663-3669
[Abstract]
[Full Text]
-
Smith, J. A., Magnuson, R. D.
(2004). Modular Organization of the Phd Repressor/Antitoxin Protein. J. Bacteriol.
186: 2692-2698
[Abstract]
[Full Text]
-
Deane, S. M., Rawlings, D. E.
(2004). Plasmid Evolution and Interaction between the Plasmid Addiction Stability Systems of Two Related Broad-Host-Range IncQ-Like Plasmids. J. Bacteriol.
186: 2123-2133
[Abstract]
[Full Text]
-
Strauss, B., Kelly, K., Dincman, T., Ekiert, D., Biesieda, T., Song, R.
(2004). Cell Death in Escherichia coli dnaE(Ts) Mutants Incubated at a Nonpermissive Temperature Is Prevented by Mutation in the cydA Gene. J. Bacteriol.
186: 2147-2155
[Abstract]
[Full Text]
-
Kaldalu, N., Mei, R., Lewis, K.
(2004). Killing by Ampicillin and Ofloxacin Induces Overlapping Changes in Escherichia coli Transcription Profile. Antimicrob. Agents Chemother.
48: 890-896
[Abstract]
[Full Text]
-
Zhang, J., Zhang, Y., Inouye, M.
(2003). Characterization of the Interactions within the mazEF Addiction Module of Escherichia coli. J. Biol. Chem.
278: 32300-32306
[Abstract]
[Full Text]
-
Loris, R., Marianovsky, I., Lah, J., Laeremans, T., Engelberg-Kulka, H., Glaser, G., Muyldermans, S., Wyns, L.
(2003). Crystal Structure of the Intrinsically Flexible Addiction Antidote MazE. J. Biol. Chem.
278: 28252-28257
[Abstract]
[Full Text]
-
Lah, J., Marianovsky, I., Glaser, G., Engelberg-Kulka, H., Kinne, J., Wyns, L., Loris, R.
(2003). Recognition of the Intrinsically Flexible Addiction Antidote MazE by a Dromedary Single Domain Antibody Fragment. STRUCTURE, THERMODYNAMICS OF BINDING, STABILITY, AND INFLUENCE ON INTERACTIONS WITH DNA. J. Biol. Chem.
278: 14101-14111
[Abstract]
[Full Text]
-
Sat, B., Reches, M., Engelberg-Kulka, H.
(2003). The Escherichia coli mazEF Suicide Module Mediates Thymineless Death. J. Bacteriol.
185: 1803-1807
[Abstract]
[Full Text]
-
Rowe-Magnus, D. A., Guerout, A.-M., Biskri, L., Bouige, P., Mazel, D.
(2003). Comparative Analysis of Superintegrons: Engineering Extensive Genetic Diversity in the Vibrionaceae. Genome Res
13: 428-442
[Abstract]
[Full Text]
-
Gong, L., Takayama, K., Kjelleberg, S.
(2002). Role of spoT-dependent ppGpp accumulation in the survival of light-exposed starved bacteria. Microbiology
148: 559-570
[Abstract]
[Full Text]
-
Hazan, R., Sat, B., Reches, M., Engelberg-Kulka, H.
(2001). Postsegregational Killing Mediated by the P1 Phage "Addiction Module" phd-doc Requires the Escherichia coli Programmed Cell Death System mazEF. J. Bacteriol.
183: 2046-2050
[Abstract]
[Full Text]